Healthcare · Diagnostics Research · NASDAQ
| Market cap | $46.22B |
|---|---|
| Trailing P/E | 41.3 |
| FCF yield | 2.2% |
| Revenue growth (YoY) | +10.4% |
| EPS growth (YoY) | +16.2% |
| FCF/share growth (YoY) | +34.4% |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics Research |
IDEXX Laboratories, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Byron Donalds | House | Buy | $1,001 - $15,000 | Oct 1, 2025 |
| Jefferson Shreve | House | Sell | $100,001 - $250,000 | May 15, 2025 |
| April McClain Delaney | House | Buy | $1,001 - $15,000 | May 1, 2025 |
| April McClain Delaney | House | Buy | $1,001 - $15,000 | May 1, 2025 |
| April McClain Delaney | House | Buy | $1,001 - $15,000 | Apr 1, 2025 |
| Rob Bresnahan | House | Buy | $1,001 - $15,000 | Feb 25, 2025 |
| Peter Meijer | House | Sell | $1,001 - $15,000 | Feb 19, 2021 |
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Mar 7, 2019 |
| Lamar Smith | House | Sell | $1,001 - $15,000 | Jul 1, 2015 |
| K. Michael Conaway | House | Sell | $1,001 - $15,000 | Feb 13, 2015 |
| Lamar Smith | House | Sell | $1,001 - $15,000 | Apr 1, 2014 |